<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR403007</article-id>
      <title-group>
        <article-title>Highly Active Antiretroviral Therapy: The Issues and Factors Deciding Adverse Drug Reactions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Narendar</surname>
            <given-names>Boggula</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>nidadavolu</surname>
            <given-names>Vijay krishna</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jogala</surname>
            <given-names>Satheesh</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>George</surname>
            <given-names>Jiji Angali</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">School of Pharmacy, Nalla  Narasimha Reddy Educational Societys Group Of Institutions- Chowdari guda, Ghatkesar, Hyderabad.</aff>
      <aff id="aff2">Mother Teresa College of Pharmacy, NFC Nagar, Ghatkesar, RR Dist, Hyderabad-501301.</aff>
      <pub-date pub-type="epub" iso-8601-date="2016-03-01">
        <month>03</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>4</volume>
      <issue>3</issue>
      <abstract>
        <p>Antiretroviral agent (ARVs) has predictable toxicities and adverse effects because they are most chronically administered drugs. It is essential that clinicians noticeably understand ADRs, eagerly identify them in patients and manage them successfully. Information on adverse drug reactions (ADRs) associated to antiretroviral (ARV) use in public health practice is signifying the requirement for ART safety surveillance in clinical care. In this article, we review the adverse effects of HAART therapy, with definite concentration to the issues and factors deciding adverse drug reactions. Our aspire is to assist physicians achieve a working knowledge of these adverse effects, with the definitive purpose of improving the tolerability and effectiveness of HIV treatment, promoting the early identification and setback of potentially serious adverse effects, and dropping the potential for adverse drug interactions.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Adverse drug reactions</kwd>
        <kwd>antiretroviral agents</kwd>
        <kwd>anti-retroviral toxicities</kwd>
        <kwd>highly active antiretroviral therapy</kwd>
        <kwd>multi-drug therapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
